ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 83 filers reported holding ADAMAS PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $1,029,000 | +11.7% | 39,827 | +3.3% | 0.01% | +12.5% |
Q1 2018 | $921,000 | -44.1% | 38,553 | -60.8% | 0.01% | -57.9% |
Q3 2015 | $1,647,000 | -56.3% | 98,380 | -31.6% | 0.02% | -13.6% |
Q2 2015 | $3,770,000 | +204.8% | 143,752 | +103.3% | 0.02% | +29.4% |
Q1 2015 | $1,237,000 | +8.7% | 70,713 | +7.9% | 0.02% | -10.5% |
Q4 2014 | $1,138,000 | +178.2% | 65,515 | +198.1% | 0.02% | +137.5% |
Q3 2014 | $409,000 | -55.4% | 21,978 | -56.2% | 0.01% | -60.0% |
Q2 2014 | $918,000 | – | 50,201 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 808,431 | $3,501,000 | 2.68% |
AIGH Capital Management LLC | 875,851 | $3,793,000 | 1.54% |
Healthcare Value Capital, LLC | 100,000 | $433,000 | 1.46% |
SILVERARC CAPITAL MANAGEMENT, LLC | 440,955 | $1,909,000 | 1.11% |
Opaleye Management Inc. | 1,487,800 | $6,442,000 | 0.84% |
Worth Venture Partners, LLC | 225,106 | $975,000 | 0.77% |
ARMISTICE CAPITAL, LLC | 2,742,000 | $11,873,000 | 0.40% |
DELTEC ASSET MANAGEMENT LLC | 245,399 | $1,063,000 | 0.16% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 278,011 | $1,204,000 | 0.15% |
Mosaic Family Wealth, LLC | 91,807 | $398,000 | 0.13% |